Literature DB >> 30423035

2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.

Anne H Norris1, Nabin K Shrestha2, Genève M Allison3, Sara C Keller4, Kavita P Bhavan5, John J Zurlo6, Adam L Hersh7, Lisa A Gorski8, John A Bosso9, Mobeen H Rathore10, Antonio Arrieta11, Russell M Petrak12, Akshay Shah13, Richard B Brown14, Shandra L Knight15, Craig A Umscheid16.   

Abstract

A panel of experts was convened by the Infectious Diseases Society of America (IDSA) to update the 2004 clinical practice guideline on outpatient parenteral antimicrobial therapy (OPAT) [1]. This guideline is intended to provide insight for healthcare professionals who prescribe and oversee the provision of OPAT. It considers various patient features, infusion catheter issues, monitoring questions, and antimicrobial stewardship concerns. It does not offer recommendations on the treatment of specific infections. The reader is referred to disease- or organism-specific guidelines for such support.

Entities:  

Year:  2019        PMID: 30423035     DOI: 10.1093/cid/ciy745

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Continued Dosing of Oritavancin for Complicated Gram-Positive Infections.

Authors:  Jodi Meyer; Paul Lata; Susanne Barnett
Journal:  Fed Pract       Date:  2020-11

2.  It's Complicated: Patient and Informal Caregiver Performance of Outpatient Parenteral Antimicrobial Therapy-Related Tasks.

Authors:  Sara C Keller; Sara E Cosgrove; Alicia I Arbaje; Rachel H Chang; Amanda Krosche; Deborah Williams; Ayse P Gurses
Journal:  Am J Med Qual       Date:  2019-06-04       Impact factor: 1.852

3.  Injection Drug Use-Associated Candidemia: Incidence, Clinical Features, and Outcomes, East Tennessee, 2014-2018.

Authors:  John A Rossow; Radhika Gharpure; Julia Brennan; Pryanka Relan; Sabrina R Williams; Snigdha Vallabhaneni; Brendan R Jackson; Caroline R Graber; Sherry R Hillis; William Schaffner; John R Dunn; Timothy F Jones
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

4.  Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy.

Authors:  L Herrera-Hidalgo; L E López-Cortes; R Luque-Márquez; J Gálvez-Acebal; A de Alarcón; L F López-Cortes; A Gutiérrez-Valencia; M V Gil-Navarro
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

5.  A Cluster of Cefepime-induced Neutropenia During Outpatient Parenteral Antimicrobial Therapy.

Authors:  Kap Sum Foong; Kevin Hsueh; Thomas C Bailey; Lan Luong; Ayesha Iqbal; Christine Hoehner; Lee Connor; Ed Casabar; Michael Lane; Yvonne Burnett; David Ritchie; Tamara Krekel; Helen Newland; Lori Weilmuenster; Brett Heuring; Michael J Durkin; Yasir Hamad
Journal:  Clin Infect Dis       Date:  2019-07-18       Impact factor: 9.079

6.  Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.

Authors:  Laura C Fanucchi; Sharon L Walsh; Alice C Thornton; Paul A Nuzzo; Michelle R Lofwall
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

7.  Nine Seasons of a Bronchiolitis Observation Unit and Home Oxygen Therapy Protocol.

Authors:  Timothy J D Ohlsen; Alexander M Knudson; E Kent Korgenski; David R Sandweiss; Michelle G Hofmann; Tiffany S Glasgow; Eric R Coon
Journal:  J Hosp Med       Date:  2021-05       Impact factor: 2.960

Review 8.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26

9.  Evaluation of Bundled Interventions for Patients With Opioid Use Disorder Experiencing Homelessness Receiving Extended Antibiotics for Severe Infection.

Authors:  Alison M Beieler; Jared W Klein; Elenore Bhatraju; Matthew Iles-Shih; Leslie Enzian; Shireesha Dhanireddy
Journal:  Open Forum Infect Dis       Date:  2021-05-29       Impact factor: 3.835

10.  Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings.

Authors:  Yoshiki Kusama; Masahiro Ishikane; Chika Tanaka; Yuki Kimura; Daisuke Yamasaki; Masaki Tanabe; Yuichi Muraki; Norio Ohmagari
Journal:  JAC Antimicrob Resist       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.